These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 15805003)
1. Acral erythema caused by high-dose methotrexate therapy in patients with osteogenic sarcoma. Postovsky S; Ben Arush MW Pediatr Hematol Oncol; 2005 Mar; 22(2):167-73. PubMed ID: 15805003 [TBL] [Abstract][Full Text] [Related]
2. [Neo-adjuvant therapy in childhood osteogenic sarcoma: a pilot study of selective postoperative chemotherapy based on response to preoperative high-dose methotrexate]. Sasaki K; Matsuoka H; Murakami T; Fujimoto T; Takayanagi F; Sawai K; Niwa J; Hara K Gan To Kagaku Ryoho; 1986 May; 13(5):1837-45. PubMed ID: 3486634 [TBL] [Abstract][Full Text] [Related]
3. Chemotherapy-induced acral erythema in a pediatric patient with acute monoblastic leukemia. Demircioğlu F; Oren H; Yilmaz S; Arslansoyu S; Eren S; Irken G Pediatr Hematol Oncol; 2008; 25(3):211-5. PubMed ID: 18432504 [TBL] [Abstract][Full Text] [Related]
4. Methotrexate-induced bullous acral erythema in a child. Werchniak AE; Chaffee S; Dinulos JG J Am Acad Dermatol; 2005 May; 52(5 Suppl 1):S93-5. PubMed ID: 15858519 [TBL] [Abstract][Full Text] [Related]
5. Successful desensitization to high-dose methotrexate after systemic anaphylaxis. Davis KA; Williams P; Walker JC Ann Allergy Asthma Immunol; 2003 Jan; 90(1):87-9. PubMed ID: 12546343 [TBL] [Abstract][Full Text] [Related]
6. [Burgdorf's reaction (painful acral erythema) in patients with acute lymphoblastic leukemia following medium-dose methotrexate therapy]. Wysocki M; Nowaczyk-Michalak A; Pilecki O; Kurylak A; Balcar-Boroń A; Trybuś L Wiad Lek; 1992 Jun; 45(11-12):462-4. PubMed ID: 1441532 [TBL] [Abstract][Full Text] [Related]
7. Variability in dose intensity of high-dose methotrexate for nonmetastatic osteosarcoma. Leavey PJ; Mantadakis E; Maale G Pediatr Hematol Oncol; 2002; 19(7):483-9. PubMed ID: 12217194 [TBL] [Abstract][Full Text] [Related]
8. [High-dose methotrexate with citrovorum factor rescue (HD-MTX-CFR) in the treatment of malignant solid tumors--clinical analysis of 62 patients]. Wang QL; Sun Y; Zhou JC; Song SZ; Feng FY; Lu L; Yie ZS Zhonghua Zhong Liu Za Zhi; 1988 Mar; 10(2):152-4. PubMed ID: 3264785 [TBL] [Abstract][Full Text] [Related]
9. Intravenous immunoglobulin in the treatment of severe methotrexate-induced acral erythema. Tezer H; Kuskonmaz B; Kara A; Devrim I; Tuncer M; Cengiz AB; Yetgin S; Seçmeer G J Pediatr Hematol Oncol; 2008 May; 30(5):391-3. PubMed ID: 18458576 [TBL] [Abstract][Full Text] [Related]
10. [Compatibility and toxicity of methotrexate in the treatment of bone tumors]. Pongracz N; Kelaridis T; Ritschl P Arzneimittelforschung; 1987 Apr; 37(4):456-60. PubMed ID: 3496891 [TBL] [Abstract][Full Text] [Related]
11. [Evaluation of severe side effects of high-dose methotrexate in osteosarcoma]. Umeda T; Takada N; Hodaka E; Endoh F; Ishii T Gan To Kagaku Ryoho; 1984 Feb; 11(2):285-94. PubMed ID: 6582805 [TBL] [Abstract][Full Text] [Related]
12. [Chemotherapy for osteosarcoma--trends in recent years]. Fujinami S; Nakaseko K; Ogihara Y Gan To Kagaku Ryoho; 1993 Oct; 20(13):1908-14. PubMed ID: 8215462 [TBL] [Abstract][Full Text] [Related]
13. [Preliminary evaluation of individualized use of large doses of methotrexate for treatment of osteosarcoma in children and adolescents]. Perek D; Jurczyk-Procyk S; Prokopczyk J; Piekarczyk A; Zelazowski J; Dembowska-Bagińska B; Wieckowska J; Witkowska-Ozogowska J; Kozera M Pediatr Pol; 1995 Nov; 70(11):929-37. PubMed ID: 8677159 [TBL] [Abstract][Full Text] [Related]
14. Acral erythema with oral methotrexate in a child. Varela CR; McNamara J; Antaya RJ Pediatr Dermatol; 2007; 24(5):541-6. PubMed ID: 17958806 [TBL] [Abstract][Full Text] [Related]
15. [Chemotherapy-induced acral erythema: a clinical and histopathologic study of 44 cases]. Hueso L; Sanmartín O; Nagore E; Botella-Estrada R; Requena C; Llombart B; Serra-Guillén C; Alfaro-Rubio A; Guillén C Actas Dermosifiliogr; 2008 May; 99(4):281-90. PubMed ID: 18394404 [TBL] [Abstract][Full Text] [Related]
16. [A case of subacute transient cerebral dysfunction in a osteosarcoma patient following high-dose methotrexate]. Yamada K; Takahashi M; Yoshida M Gan To Kagaku Ryoho; 2002 Mar; 29(3):469-72. PubMed ID: 11915742 [TBL] [Abstract][Full Text] [Related]
17. Acral erythema in children receiving high-dose methotrexate. Millot F; Auriol F; Brecheteau P; Guilhot F Pediatr Dermatol; 1999; 16(5):398-400. PubMed ID: 10571844 [TBL] [Abstract][Full Text] [Related]
19. No correlation between methotrexate serum level and histologic response in the pre-operative treatment of extremity osteosarcoma. Bacci G; Loro L; Longhi A; Bertoni F; Bacchini P; Versari M; Picci P; Serra M Anticancer Drugs; 2006 Apr; 17(4):411-5. PubMed ID: 16549998 [TBL] [Abstract][Full Text] [Related]
20. [Toxicosis of high-dose methotrexate (HD-MTX) for osteosarcoma, cured with treatment by leucovorin (LV) rescue and hemoperfusion--a case report]. Kobayashi H; Morita T; Hirata Y; Kato T; Okada Y; Sato T Gan To Kagaku Ryoho; 2000 Mar; 27(3):475-8. PubMed ID: 10740644 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]